Heterozygous APC germline mutations impart predisposition to colorectal cancer

Abstract Familial adenomatous polyposis (FAP) is an inherited syndrome caused by a heterozygous adenomatous polyposis coli (APC) germline mutation, associated with a profound lifetime risk for colorectal cancer. While it is well accepted that tumorigenic transformation is initiated following acquisi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Livia Preisler, Aline Habib, Guy Shapira, Liron Kuznitsov-Yanovsky, Yoav Mayshar, Ilana Carmel-Gross, Mira Malcov, Foad Azem, Noam Shomron, Revital Kariv, Dov Hershkovitz, Dalit Ben-Yosef
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1cd322207da747e2ac2ab6d15bbd29d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1cd322207da747e2ac2ab6d15bbd29d1
record_format dspace
spelling oai:doaj.org-article:1cd322207da747e2ac2ab6d15bbd29d12021-12-02T15:53:58ZHeterozygous APC germline mutations impart predisposition to colorectal cancer10.1038/s41598-021-84564-42045-2322https://doaj.org/article/1cd322207da747e2ac2ab6d15bbd29d12021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84564-4https://doaj.org/toc/2045-2322Abstract Familial adenomatous polyposis (FAP) is an inherited syndrome caused by a heterozygous adenomatous polyposis coli (APC) germline mutation, associated with a profound lifetime risk for colorectal cancer. While it is well accepted that tumorigenic transformation is initiated following acquisition of a second mutation and loss of function of the APC gene, the role of heterozygous APC mutation in this process is yet to be discovered. This work aimed to explore whether a heterozygous APC mutation induces molecular defects underlying tumorigenic transformation and how different APC germline mutations predict disease severity. Three FAP-human embryonic stem cell lines (FAP1/2/3-hESC lines) carrying germline mutations at different locations of the APC gene, and two control hESC lines free of the APC mutation, were differentiated into colon organoids and analyzed by immunohistochemistry and RNA sequencing. In addition, data regarding the genotype and clinical phenotype of the embryo donor parents were collected from medical records. FAP-hESCs carrying a complete loss-of-function of a single APC allele (FAP3) generated complex and molecularly mature colon organoids, which were similar to controls. In contrast, FAP-hESCs carrying APC truncation mutations (FAP1 and FAP2) generated only few cyst-like structures and cell aggregates of various shape, occasionally with luminal parts, which aligned with their failure to upregulate critical differentiation genes early in the process, as shown by RNA sequencing. Abnormal disease phenotype was shown also in non-pathological colon of FAP patients by the randomly distribution of proliferating cells throughout the crypts, compared to their focused localization in the lower part of the crypt in healthy/non-FAP patients. Genotype/phenotype analysis revealed correlations between the colon organoid maturation potential and FAP severity in the carrier parents. In conclusion, this study suggest that a single truncated APC allele is sufficient to initiate early molecular tumorigenic activity. In addition, the results hint that patient-specific hESC-derived colon organoids can probably predict disease severity among FAP patients.Livia PreislerAline HabibGuy ShapiraLiron Kuznitsov-YanovskyYoav MaysharIlana Carmel-GrossMira MalcovFoad AzemNoam ShomronRevital KarivDov HershkovitzDalit Ben-YosefNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Livia Preisler
Aline Habib
Guy Shapira
Liron Kuznitsov-Yanovsky
Yoav Mayshar
Ilana Carmel-Gross
Mira Malcov
Foad Azem
Noam Shomron
Revital Kariv
Dov Hershkovitz
Dalit Ben-Yosef
Heterozygous APC germline mutations impart predisposition to colorectal cancer
description Abstract Familial adenomatous polyposis (FAP) is an inherited syndrome caused by a heterozygous adenomatous polyposis coli (APC) germline mutation, associated with a profound lifetime risk for colorectal cancer. While it is well accepted that tumorigenic transformation is initiated following acquisition of a second mutation and loss of function of the APC gene, the role of heterozygous APC mutation in this process is yet to be discovered. This work aimed to explore whether a heterozygous APC mutation induces molecular defects underlying tumorigenic transformation and how different APC germline mutations predict disease severity. Three FAP-human embryonic stem cell lines (FAP1/2/3-hESC lines) carrying germline mutations at different locations of the APC gene, and two control hESC lines free of the APC mutation, were differentiated into colon organoids and analyzed by immunohistochemistry and RNA sequencing. In addition, data regarding the genotype and clinical phenotype of the embryo donor parents were collected from medical records. FAP-hESCs carrying a complete loss-of-function of a single APC allele (FAP3) generated complex and molecularly mature colon organoids, which were similar to controls. In contrast, FAP-hESCs carrying APC truncation mutations (FAP1 and FAP2) generated only few cyst-like structures and cell aggregates of various shape, occasionally with luminal parts, which aligned with their failure to upregulate critical differentiation genes early in the process, as shown by RNA sequencing. Abnormal disease phenotype was shown also in non-pathological colon of FAP patients by the randomly distribution of proliferating cells throughout the crypts, compared to their focused localization in the lower part of the crypt in healthy/non-FAP patients. Genotype/phenotype analysis revealed correlations between the colon organoid maturation potential and FAP severity in the carrier parents. In conclusion, this study suggest that a single truncated APC allele is sufficient to initiate early molecular tumorigenic activity. In addition, the results hint that patient-specific hESC-derived colon organoids can probably predict disease severity among FAP patients.
format article
author Livia Preisler
Aline Habib
Guy Shapira
Liron Kuznitsov-Yanovsky
Yoav Mayshar
Ilana Carmel-Gross
Mira Malcov
Foad Azem
Noam Shomron
Revital Kariv
Dov Hershkovitz
Dalit Ben-Yosef
author_facet Livia Preisler
Aline Habib
Guy Shapira
Liron Kuznitsov-Yanovsky
Yoav Mayshar
Ilana Carmel-Gross
Mira Malcov
Foad Azem
Noam Shomron
Revital Kariv
Dov Hershkovitz
Dalit Ben-Yosef
author_sort Livia Preisler
title Heterozygous APC germline mutations impart predisposition to colorectal cancer
title_short Heterozygous APC germline mutations impart predisposition to colorectal cancer
title_full Heterozygous APC germline mutations impart predisposition to colorectal cancer
title_fullStr Heterozygous APC germline mutations impart predisposition to colorectal cancer
title_full_unstemmed Heterozygous APC germline mutations impart predisposition to colorectal cancer
title_sort heterozygous apc germline mutations impart predisposition to colorectal cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1cd322207da747e2ac2ab6d15bbd29d1
work_keys_str_mv AT liviapreisler heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT alinehabib heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT guyshapira heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT lironkuznitsovyanovsky heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT yoavmayshar heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT ilanacarmelgross heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT miramalcov heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT foadazem heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT noamshomron heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT revitalkariv heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT dovhershkovitz heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
AT dalitbenyosef heterozygousapcgermlinemutationsimpartpredispositiontocolorectalcancer
_version_ 1718385497788645376